Head of Pancreatic Surgery, Dept of HPB Surgery.; MD, PhD
+47 22 11 96 24
Recent publications
Amrutkar M, Berg K, Balto A, Skilbrei MG, Finstadsveen AV, Aasrum M, Gladhaug IP, Verbeke CS(2023) Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis Cancer Cell Int, 23(1), 9 DOI 10.1186/s12935-023-02852-7, PubMed 36658582
van Veldhuisen E, Klompmaker S, Janssen QP, Hilal MA, Alseidi A, Balduzzi A, Balzano G, Bassi C, Berrevoet F, Bonds M, Busch OR, Butturini G, Conlon KC, Frigerio IM, Fusai GK, Gagnière J, Griffin O, Hackert T, Halimi A, Keck T, Kleeff J, Klaiber U, Labori KJ, Lesurtel M, Malleo Get al.(2022) Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study Ann Surg Oncol(in press) DOI 10.1245/s10434-022-12387-2, PubMed 36539580
Amrutkar M, Verbeke CS, Finstadsveen AV, Dorg L, Labori KJ, Gladhaug IP(2022) Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma Mol Oncol, 17(1), 59-81 DOI 10.1002/1878-0261.13344, PubMed 36400567